$PTEN
PATTERSON UTI ENERGY INC Stock $pten

$pten Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000162828024020701 Filed on May 06, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$1.348B	$1.510B	$791.8M
YoY Change	77.65%	90.75%	55.45%
Cost Of Revenue	$971.2M	$1.077B	$512.7M
YoY Change	98.97%	110.11%	33.78%
Gross Profit	$377.0M	$433.2M	$279.1M
YoY Change	39.23%	55.2%	121.26%
Gross Profit Margin	27.97%	28.68%	35.25%
Selling, General & Admin	$64.58M	$64.98M	$30.57M
YoY Change	94.18%	112.6%	11.31%
% of Gross Profit	17.13%	15.0%	10.95%
Research & Development			$136.0K
YoY Change			-44.49%
% of Gross Profit			0.05%
Depreciation & Amortization	$267.6M	$275.0M	$128.2M
YoY Change	111.05%	114.51%	9.61%
% of Gross Profit	70.99%	63.47%	45.92%
Operating Expenses	$64.58M	$64.98M	$30.57M
YoY Change	-59.76%	112.6%	11.31%
Operating Profit	$45.23M	$87.00M	$126.0M
YoY Change	-59.0%	-30.93%	-767.14%
Interest Expense	-$16.05M	$18.34M	$8.826M
YoY Change	88.2%	107.74%	-16.46%
% of Operating Profit	-35.48%	21.07%	7.01%
Other Income/Expense, Net	-$15.82M	-$15.30M	-$6.100M
YoY Change	-781.1%	150.75%	-31.98%
Pretax Income	$29.41M	$71.70M	$119.9M
YoY Change	-70.11%	-40.18%	-530.4%
Income Tax	$17.79M	$20.00M	$20.19M
% Of Pretax Income	60.48%	27.89%	16.84%
Net Earnings	$11.08M	$51.24M	$99.68M
YoY Change	-86.91%	-48.6%	-446.38%
Net Earnings / Revenue	0.82%	3.39%	12.59%
Basic Earnings Per Share	$0.03	$0.13	$0.47
Diluted Earnings Per Share	$0.03	$0.13	$0.46
COMMON SHARES
Basic Shares Outstanding	401.7M shares	408.2M	213.7M
Diluted Shares Outstanding	399.6M shares	409.8M shares	215.9M

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$75.04M	$170.2M	$157.2M
YoY Change	-50.07%	8.29%	225.75%
Cash & Equivalents	$72.44M	$167.7M	$157.2M
Short-Term Investments
Other Short-Term Assets	$165.0M	$128.5M	$64.21M
YoY Change	79.44%	100.12%	4.06%
Inventory	$172.4M	$183.2M	$65.28M
Prepaid Expenses	$50.39M	$33.16M	$7.923M
Receivables	$866.9M	$872.8M	$493.0M
Other Receivables	$35.73M	$25.98M	$525.0K
Total Short-Term Assets	$1.279B	$1.355B	$780.3M
YoY Change	59.66%	73.62%	46.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.236B	$3.319B	$2.253B
YoY Change	41.79%	47.3%	-2.26%
Goodwill	$1.377B	$1.380B
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$21.57M	$18.60M	$10.53M
YoY Change	-23.99%	76.57%	-17.58%
Total Long-Term Assets	$5.743B	$5.871B	$2.312B
YoY Change	147.98%	153.95%	-1.87%
TOTAL ASSETS
Total Short-Term Assets	$1.279B	$1.355B	$780.3M
Total Long-Term Assets	$5.743B	$5.871B	$2.312B
Total Assets	$7.022B	$7.226B	$3.092B
YoY Change	125.28%	133.68%	7.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$476.5M	$544.9M	$271.4M
YoY Change	94.03%	100.73%	31.26%
Accrued Expenses	$329.2M	$324.0M	$204.0M
YoY Change	73.66%	58.78%	11.88%
Deferred Revenue	$14.05M	$22.02M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$12.59M	$12.41M
YoY Change
Total Short-Term Liabilities	$851.2M	$916.9M	$486.8M
YoY Change	87.36%	88.34%	22.88%
LONG-TERM LIABILITIES
Long-Term Debt	$1.219B	$1.221B	$822.2M
YoY Change	48.24%	48.51%	-3.56%
Other Long-Term Liabilities	$14.05M	$16.17M	$44.58M
YoY Change	-77.22%	-63.72%	177.89%
Total Long-Term Liabilities	$1.233B	$1.237B	$866.8M
YoY Change	39.49%	42.74%	-0.21%
TOTAL LIABILITIES
Total Short-Term Liabilities	$851.2M	$916.9M	$486.8M
Total Long-Term Liabilities	$1.233B	$1.237B	$866.8M
Total Liabilities	$2.414B	$2.474B	$1.419B
YoY Change	72.78%	74.32%	8.16%
SHAREHOLDERS EQUITY
Retained Earnings	$54.21M	$75.30M	-$4.895M
YoY Change	-13.82%	-1638.2%	-97.92%
Common Stock	$6.435B	$6.425B	$3.205B
YoY Change	100.35%	100.44%	0.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.890B	$1.756B	$1.527B
YoY Change	21.55%	14.99%	11.27%
Treasury Stock Shares			$94.39M
Shareholders Equity	$4.599B	$4.743B	$1.673B
YoY Change
Total Liabilities & Shareholders Equity	$7.022B	$7.226B	$3.092B
YoY Change	125.28%	133.68%	7.04%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	$11.08M	$51.24M	$99.68M
YoY Change	-86.91%	-48.6%	-446.38%
Depreciation, Depletion And Amortization	$267.6M	$275.0M	$128.2M
YoY Change	111.05%	114.51%	9.61%
Cash From Operating Activities	$197.5M	$365.9M	$234.3M
YoY Change	21.29%	56.13%	595.93%
INVESTING ACTIVITIES
Capital Expenditures	$130.5M	$226.9M	$117.6M
YoY Change	-1.42%	92.98%	24.02%
Acquisitions
YoY Change
Other Investing Activities	$8.489M	-$544.0K	$1.256M
YoY Change	30.06%	-143.31%	-13.97%
Cash From Investing Activities	-$122.0M	-$227.5M	-$116.3M
YoY Change	-3.06%	95.53%	24.61%
FINANCING ACTIVITIES
Cash Dividend Paid		$32.55M	$16.92M
YoY Change		92.44%	96.45%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-170.9M	-$161.6M	-98.34M
YoY Change	289.23%	64.32%	1040.29%
NET CHANGE
Cash From Operating Activities	197.5M	$365.9M	234.3M
Cash From Investing Activities	-122.0M	-$227.5M	-116.3M
Cash From Financing Activities	-170.9M	-$161.6M	-98.34M
Net Change In Cash	-95.45M	-$22.43M	19.67M
YoY Change	1277.29%	-214.08%	-128.39%
FREE CASH FLOW
Cash From Operating Activities	$197.5M	$365.9M	$234.3M
Capital Expenditures	$130.5M	$226.9M	$117.6M
Free Cash Flow	$67.01M	$139.0M	$116.7M
YoY Change	119.98%	19.02%	-290.91%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	192680000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	137553000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P9M
CY2024Q1	pten	Share Based Payment Arrangement Performance Goal Total Shareholder Return During Performance Period Compared To Peer Group At25th Percentile Number Of Target Shares To Be Received ShareBasedPaymentArrangementPerformanceGoalTotalShareholderReturnDuringPerformancePeriodComparedToPeerGroupAt25thPercentileNumberOfTargetSharesToBeReceived	0.5
CY2024Q1	us-gaap	Revenues Revenues	1510360000	usd
CY2023Q1	us-gaap	Revenues Revenues	791802000	usd
CY2024Q1	pten	Depreciation Depletion Amortization And Impairment DepreciationDepletionAmortizationAndImpairment	274956000	usd
CY2023Q1	pten	Depreciation Depletion Amortization And Impairment DepreciationDepletionAmortizationAndImpairment	128180000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	64984000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	30566000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5231000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2024Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	12233000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
CY2024Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	11182000	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	5566000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	1423361000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	665839000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	86999000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	125963000	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	2189000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	1240000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	18335000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	8826000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	850000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1486000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-15296000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6100000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	71703000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	119863000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19997000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20185000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	51706000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	99678000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	471000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	51235000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	99678000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.47
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.46
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	408182000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	212089000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	409819000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	215866000	shares
CY2024Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.08
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.08
CY2024Q1	us-gaap	Profit Loss ProfitLoss	51706000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	99678000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	0	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-993000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	50713000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	99678000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	471000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	50242000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	99678000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4820681000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	51706000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-993000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-993000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12051000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.08
CY2024Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	32553000	usd
CY2024Q1	pten	Dividend Equivalents DividendEquivalents	422000	usd
CY2024Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	98613000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4751857000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1665523000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	99678000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-758000	usd
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	16916000	usd
CY2023Q1	pten	Dividend Equivalents DividendEquivalents	263000	usd
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	74307000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1672957000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	51706000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	99678000	usd
CY2024Q1	pten	Depreciation Depletion Amortization And Impairment DepreciationDepletionAmortizationAndImpairment	274956000	usd
CY2023Q1	pten	Depreciation Depletion Amortization And Impairment DepreciationDepletionAmortizationAndImpairment	128180000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	19507000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	18303000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	12051000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	-758000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	2668000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-538000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5231000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-613000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	648000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-95119000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-72482000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10585000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9634000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-14334000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-4342000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-8390000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-1990000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	35401000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	24329000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-125191000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-99434000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-12973000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-5019000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	365891000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	234349000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	226941000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	117601000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	2389000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	1263000	usd
CY2024Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	2933000	usd
CY2023Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	7000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-227485000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-116345000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	97782000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	73586000	usd
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	32553000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	16916000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	27229000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
CY2024Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-4025000	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-7837000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-161589000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-98339000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	750000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	0	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-22433000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	19665000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	170247000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	157218000	usd
CY2024Q1	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	216000	usd
CY2023Q1	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	351000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	10037000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	8871000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-383000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-335000	usd
CY2024Q1	pten	Increase Decrease In Payables Related To Purchases Of Property And Equipment IncreaseDecreaseInPayablesRelatedToPurchasesOfPropertyAndEquipment	-24869000	usd
CY2023Q1	pten	Increase Decrease In Payables Related To Purchases Of Property And Equipment IncreaseDecreaseInPayablesRelatedToPurchasesOfPropertyAndEquipment	10057000	usd
CY2024Q1	pten	Net Decrease Increase In Deposits On Equipment Purchases NetDecreaseIncreaseInDepositsOnEquipmentPurchases	-13552000	usd
CY2023Q1	pten	Net Decrease Increase In Deposits On Equipment Purchases NetDecreaseIncreaseInDepositsOnEquipmentPurchases	-6072000	usd
CY2024Q1	pten	Property And Equipment Through Exchange Of Lease Right Of Use Asset PropertyAndEquipmentThroughExchangeOfLeaseRightOfUseAsset	26133000	usd
CY2023Q1	pten	Property And Equipment Through Exchange Of Lease Right Of Use Asset PropertyAndEquipmentThroughExchangeOfLeaseRightOfUseAsset	0	usd
CY2024Q1	pten	Derecognition Of Right Of Use Asset DerecognitionOfRightOfUseAsset	-31179000	usd
CY2023Q1	pten	Derecognition Of Right Of Use Asset DerecognitionOfRightOfUseAsset	0	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	167665000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	157218000	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	2582000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	0	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	170247000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	157218000	usd
CY2023Q4	pten	Accrued Salaries Wages Payroll Taxes And Benefits Current AccruedSalariesWagesPayrollTaxesAndBenefitsCurrent	129982000	usd
CY2024Q1	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	68365000	usd
CY2023Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	67396000	usd
CY2024Q1	pten	Property Sales Use And Other Taxes Current PropertySalesUseAndOtherTaxesCurrent	59853000	usd
CY2023Q4	pten	Property Sales Use And Other Taxes Current PropertySalesUseAndOtherTaxesCurrent	62194000	usd
CY2024Q1	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	10687000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	23800000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	103000000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	84700000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	22000000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1800000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	527000000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.14
CY2024Q1	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	141278000	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	141311000	usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	8226000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	7437000	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	33674000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	32057000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	183178000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	180805000	usd
CY2024Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	25977000	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	26949000	usd
CY2024Q1	pten	Workers Compensation Receivable WorkersCompensationReceivable	30632000	usd
CY2023Q4	pten	Workers Compensation Receivable WorkersCompensationReceivable	31006000	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	33156000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	46394000	usd
CY2024Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	38739000	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	36773000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	128504000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	141122000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9303595000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9152221000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5984250000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5811809000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3319345000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3340412000	usd
CY2024Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1379741000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	1379741000	usd
CY2023Q4	us-gaap	Number Of Reporting Units NumberOfReportingUnits	3	reportingunit
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1099644000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	76640000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1023004000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1097832000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	46135000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1051697000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	30500000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	800000	usd
CY2024Q1	pten	Accrued Salaries Wages Payroll Taxes And Benefits Current AccruedSalariesWagesPayrollTaxesAndBenefitsCurrent	91607000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	409819000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	215866000	shares
CY2023Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	11524000	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	10241000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	19172000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	22016000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	98914000	usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2055000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	3437000	usd
CY2024Q1	pten	Accrued Restructuring Expense Current AccruedRestructuringExpenseCurrent	12861000	usd
CY2023Q4	pten	Accrued Restructuring Expense Current AccruedRestructuringExpenseCurrent	15113000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	46299000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	38536000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	323984000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	446268000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1242061000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1246086000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	8597000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	8919000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	12406000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	12226000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1221058000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1224941000	usd
CY2015Q1	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.0150
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	8265000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	6396000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	482505000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	344895000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	400000000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	1242061000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	99678000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	408182000	shares
CY2024Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	87200000	usd
CY2024Q1	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	158000000	usd
CY2024Q1	us-gaap	Unrecorded Unconditional Purchase Obligation Balance Sheet Amount UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount	31800000	usd
CY2024Q1	us-gaap	Unrecorded Unconditional Purchase Obligation Due In Remainder Of Fiscal Year UnrecordedUnconditionalPurchaseObligationDueInRemainderOfFiscalYear	25900000	usd
CY2024Q1	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On First Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary	4000000	usd
CY2024Q1	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Second Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary	2000000	usd
CY2024Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	1000000000	usd
CY2024Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	945000000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	105580011	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1657675000	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	114330726	shares
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	1756288000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2865223	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	23.36
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	192099	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	20.78
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2673124	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	23.54
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2673124	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	23.54
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	212089000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.47
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	51235000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	99678000	usd
CY2024Q1	pten	Share Based Payment Arrangement Performance Payout May Not Exceed Target Number Of Shares If Absolute Tsr Threshold ShareBasedPaymentArrangementPerformancePayoutMayNotExceedTargetNumberOfSharesIfAbsoluteTSRThreshold	0
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.279
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.168
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	51235000	usd
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.46
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2673000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2905000	shares
CY2024Q1	us-gaap	Revenues Revenues	1510360000	usd
CY2023Q1	us-gaap	Revenues Revenues	791802000	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	2189000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	1240000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	18335000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	8826000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	850000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1486000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	71703000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	119863000	usd
CY2024Q1	pten	Depreciation Depletion Amortization And Impairment DepreciationDepletionAmortizationAndImpairment	274956000	usd
CY2023Q1	pten	Depreciation Depletion Amortization And Impairment DepreciationDepletionAmortizationAndImpairment	128180000	usd
CY2024Q1	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	226941000	usd
CY2023Q1	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	117601000	usd
CY2024Q1	us-gaap	Assets Assets	7226188000	usd
CY2023Q4	us-gaap	Assets Assets	7420031000	usd
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
pten-20240331_cal.xml	Edgar Link	unprocessable
0001628280-24-020701-index-headers.html	Edgar Link	pending
0001628280-24-020701-index.html	Edgar Link	pending
0001628280-24-020701.txt	Edgar Link	pending
0001628280-24-020701-xbrl.zip	Edgar Link	pending
ex101commitmentincreaseagr.htm	Edgar Link	pending
ex311302certificationofceo.htm	Edgar Link	pending
ex312302certificationofcfo.htm	Edgar Link	pending
ex321906certification2024q1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pten-20240331.htm	Edgar Link	pending
pten-20240331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
pten-20240331_def.xml	Edgar Link	unprocessable
pten-20240331_lab.xml	Edgar Link	unprocessable
pten-20240331_pre.xml	Edgar Link	unprocessable
pten-20240331_htm.xml	Edgar Link	completed
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PTEN
PATTERSON UTI ENERGY INC Stock $pten

2024 Q2 Form 10-Q Financial Statement

#000162828024020701 Filed on May 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PTEN PATTERSON UTI ENERGY INC Stock $pten

2024 Q2 Form 10-Q Financial Statement

#000162828024020701 Filed on May 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PTEN
PATTERSON UTI ENERGY INC Stock $pten